BIM 21009
BIM 21009 is a LHRH and GnRH receptor antagonist. BIM 21009 inhibits tumor growth.
For research use only. We do not sell to patients.
- CAS No.: 106881-54-3
- Formula: C74H92ClN17O13
- Molecular Weight:1463.08
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 106881-54-3
-
Molecular Weight 1463.08
-
Formula C74H92ClN17O13
-
Sequence
Ac-{d-Nal}-{d-Cl-Phe}-{d-Phe}-Ser-Tyr-{d-Arg}-Phe-Arg-Pro-{d-Ala}-NH2
-
Sequence Shortening
Ac-{d-Nal}-{d-Cl-Phe}-{d-Phe}-SY-{d-Arg}-FRP-{d-Ala}-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Ban E, Crumeyrolle-Arias M, Latouche J, Leblanc P, Heurtier JF, Drieu K, Fillion G, Haour F. GnRH receptors in rat brain, pituitary and testis; modulation following surgical and gonadotropin-releasing hormone agonist-induced castration. Mol Cell Endocrinol. 1990 Mar 26;70(1):99-107. [Content Brief]
[2]. Bogden AE,et al. Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration. Cancer Res. 1990 May 1;50(9):2646-50. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)